A Rebuttal to Mark Lynas’ GMO Reversal
By Jason Mark,
Earth Island Journal
| 01. 11. 2013
If you want to get your name splattered all over the web, there’s nothing like recanting your once strongly held beliefs. Give a big
mea culpa speech telling the world how wrong you have been, and you’ll get far more attention for your auto-rebuttal than you ever received for your original ideas. When it comes to ideological U-turns the media are like moths to a flame. (Never mind that, as Whitman said, “consistency is the hobgoblin of small minds.”)
In this case, I’m talking about the recent “big news” that one-time GMO critic
Mark Lynas — a Brit who at least once took direct action to rip GM trial crops out of the ground — has come out as a supporter of the technology he once abhorred. You can find write-ups about it from
Andrew Revkin and
Slate and the
LA Times and
The New Yorker’s Michael Specter. I even got an email from the folks at the No on 37 campaign (the people who successfully fought a GMO labeling referendum in California) trumpeting the news.
Here’s the opening...
Related Articles
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...
By Shelly Fan, Singularity Hub | 05.31.2024
We all know the drill for reproduction—sperm meets egg.
For the past decade, scientists have been pushing the boundaries of where the two halves come from. Thanks to induced pluripotent stem cell technology, it’s now possible to scrape skin cells...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...